secwatch.observer — SEC 8-K summary
======================================

Issuer:     NutriBand Inc. (NTRB)
CIK:        0001676047
Form:       8-K
Filed at:   2026-04-07T23:59:59+00:00
Accession:  0001213900-26-041006
Event type: other_material
Sentiment:  positive
Materiality: 0.65
Item codes: 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Nutriband selects brand name for abuse-deterrent fentanyl patch; will submit to FDA
--------------------------------------------------------------------------------

- Selected commercial worldwide brand name candidate for lead product, a fentanyl transdermal system with abuse-deterrent technology.
- Will submit proposed brand name and labeling to FDA and international regulators for review and approval; also filing for trademark registration.
- Engaged Brand Institute, global leader with 75% share of drug name approvals and 87% of FDA-approved names in 2024.
- Product uses AVERSA abuse-deterrent technology; potential peak annual US sales of $80-200 million per market report.
- Brand Institute's regulatory subsidiary DSI, led by former FDA/EMA officials, will provide regulatory support.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1676047/000121390026041006/0001213900-26-041006-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1676047/000121390026041006/ea0285330-8k_nutriband.htm
  HTML page:      https://secwatch.observer/filing/0001213900-26-041006

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer